{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:06:52Z","timestamp":1791198412034,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/chi.0b013e318185d2be","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T07:08:36Z","timestamp":1224140916000},"page":"1262-1272","source":"Crossref","is-referenced-by-count":67,"title":["Brain Imaging in Pediatric Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"47","author":[{"given":"Frank P.","family":"MacMaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/ajp.152.1.76","article-title":"A family study of obsessive-compulsive disorder","volume":"152","author":"Pauls","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0006-3223(97)00443-5","article-title":"Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder","volume":"43","author":"Rosenberg","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318185d2be_bib3","series-title":"Handbook of Child and Adolescent Obsessive-Compulsive Disorder","first-page":"131","article-title":"Neurobiology, neuropsychology and neuroimaging of child and adolescent obsessive-compulsive disorder","author":"Rosenberg","year":"2007"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib4","first-page":"29","article-title":"Response-inhibition deficits in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal circuits","volume":"22","author":"Rosenberg","year":"1997","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1176\/ajp.156.5.777","article-title":"Neuropsychological study of frontal lobe function in psychotropic-naive children with obsessive-compulsive disorder","volume":"156","author":"Beers","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/13825580600966383","article-title":"Neurocognitive correlates of child obsessive compulsive disorder and Tourette syndrome","volume":"29","author":"Chang","year":"2007","journal-title":"J Clin Exp Neuropsychol"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archpsyc.1997.01830210075008","article-title":"Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder","volume":"54","author":"Rosenberg","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1192\/bjp.bp.107.036558","article-title":"Brain activation in paediatric obsessive compulsive disorder during tasks of inhibitory control","volume":"192","author":"Woolley","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1097\/CHI.0b013e318185d2be_bib9","doi-asserted-by":"crossref","unstructured":"Szeszko P, Christian C, MacMaster FP, et al. Gray matter structural alterations in psychotropic drug-na\u00efve pediatric obsessive-compulsive disorder: an optimized voxel based morphometry study. Am J Psychiatry. Published online ahead of print April 15, 2008.","DOI":"10.1176\/appi.ajp.2008.08010033"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1989.01810060038007","article-title":"Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder","volume":"46","author":"Swedo","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/appi.ajp.161.6.1049","article-title":"Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder","volume":"161","author":"Szeszko","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2007.05.047","article-title":"Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study","volume":"421","author":"Carmona","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1097\/CHI.0b013e318185d2be_bib14","series-title":"Tutorial: A Critical Analysis of Voxel Based Morphometry (VBM)","author":"Thacker","year":"2005"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.chi.0000132812.44664.2d","article-title":"Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls","volume":"43","author":"Rosenberg","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Yucel","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"issue":"suppl 1","key":"10.1097\/CHI.0b013e318185d2be_bib17","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1089\/104454603322126322","article-title":"Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder","volume":"13","author":"Russell","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.1997.01830210068007","article-title":"Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder","volume":"54","author":"Rosenberg","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1097\/CHI.0b013e318185d2be_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0278-5846(97)00163-2","article-title":"Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder","volume":"21","author":"Rosenberg","year":"1997","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0278-5846(99)00019-6","article-title":"Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorders","volume":"23","author":"MacMaster","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1097\/CHI.0b013e318185d2be_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.chi.0000087562.01900.de","article-title":"Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy","volume":"42","author":"Benazon","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archpsyc.57.5.449","article-title":"Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine","volume":"57","author":"Gilbert","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0006-3223(00)00902-1","article-title":"Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy","volume":"48","author":"Rosenberg","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-3223(99)00286-3","article-title":"Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder","volume":"47","author":"Fitzgerald","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/088307380101600902","article-title":"Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging","volume":"16","author":"Rosenberg","year":"2001","journal-title":"J Child Neurol"},{"issue":"12","key":"10.1097\/CHI.0b013e318185d2be_bib27","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-3223(03)00474-8","article-title":"Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study","volume":"54","author":"Smith","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/08830738060210020201","article-title":"Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls","volume":"21","author":"Mirza","year":"2006","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.npp.1300399","article-title":"Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings","volume":"29","author":"Szeszko","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopsych.2005.06.028","article-title":"Pituitary volume in pediatric obsessive-compulsive disorder","volume":"59","author":"MacMaster","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1097\/CHI.0b013e318185d2be_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2008.02.011","article-title":"Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study","volume":"435","author":"Gilbert","year":"2008","journal-title":"Neurosci Lett"},{"issue":"8","key":"10.1097\/CHI.0b013e318185d2be_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/01.wnl.0000180957.98702.69","article-title":"Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome","volume":"65","author":"Bloch","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004583-199806000-00017","article-title":"Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder","volume":"37","author":"Moore","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1097\/CHI.0b013e318185d2be_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00004583-200108000-00011","article-title":"Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD","volume":"40","author":"Bolton","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/appi.ajp.163.6.1106","article-title":"Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyper-activity disorder","volume":"163","author":"Amat","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(92)91326-A","article-title":"Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro","volume":"593","author":"Altemus","year":"1992","journal-title":"Brain Res"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000119352","article-title":"Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect","volume":"36","author":"Monteleone","year":"1997","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0306-4530(95)00013-5","article-title":"Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment","volume":"20","author":"Monteleone","year":"1995","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0165-1781(92)90025-X","article-title":"Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder","volume":"44","author":"Catapano","year":"1992","journal-title":"Psychiatry Res"},{"key":"10.1097\/CHI.0b013e318185d2be_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2003.11.001","article-title":"Pituitary gland volume in adolescent depression","author":"MacMaster","year":"2004","journal-title":"J Psychiatr Res"},{"issue":"8","key":"10.1097\/CHI.0b013e318185d2be_bib41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biopsych.2006.04.013","article-title":"Pituitary volume in treatment-naive pediatric major depressive disorder","volume":"60","author":"MacMaster","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-5618.2008.00476.x","article-title":"Pituitary gland volume in adolescent and young adult bipolar and unipolar depression","volume":"10","author":"MacMaster","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1097\/CHI.0b013e318185d2be_bib43","series-title":"Regional Volumetric Changes With Treatment in Pediatric Major Depression","author":"MacMaster","year":"2008"},{"issue":"1\u20133","key":"10.1097\/CHI.0b013e318185d2be_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2007.01.022","article-title":"Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study","volume":"92","author":"MacMaster","year":"2007","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0272-7358(99)00044-6","article-title":"Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?","volume":"21","author":"Eichstedt","year":"2001","journal-title":"Clin Psychol Rev"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00004583-199607000-00017","article-title":"Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy","volume":"35","author":"Giedd","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.157.2.281","article-title":"MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection","volume":"157","author":"Giedd","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1375\/twin.8.5.450","article-title":"Twin studies on obsessive-compulsive disorder: a review","volume":"8","author":"van Grootheest","year":"2005","journal-title":"Twin Res Hum Genet"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","article-title":"Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder","volume":"63","author":"Arnold","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","article-title":"Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder","volume":"63","author":"Dickel","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1097\/CHI.0b013e318185d2be_bib51","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajmg.b.30533","article-title":"Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder","volume":"144","author":"Stewart","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse","volume":"9","author":"Aoyama","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1097\/CHI.0b013e318185d2be_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2091-7-10","article-title":"EAAC1 is expressed in rat and human prostate epithelial cells; functions as a high-affinity l-aspartate transporter; and is regulated by prolactin and testosterone","volume":"7","author":"Franklin","year":"2006","journal-title":"BMC Biochem"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuint.2004.10.006","article-title":"Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures","volume":"46","author":"Guillet","year":"2005","journal-title":"Neurochem Int"},{"issue":"pt 2","key":"10.1097\/CHI.0b013e318185d2be_bib55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1113\/jphysiol.1996.sp021393","article-title":"Interaction of l-cysteine with a human excitatory amino acid transporter","volume":"493","author":"Zerangue","year":"1996","journal-title":"J Physiol"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0896-6273(94)90038-8","article-title":"Localization of neuronal and glial glutamate transporters","volume":"13","author":"Rothstein","year":"1994","journal-title":"Neuron"},{"issue":"15","key":"10.1097\/CHI.0b013e318185d2be_bib57","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fasebj.7.15.7903261","article-title":"A new family of neurotransmitter transporters: the high-affinity glutamate transporters","volume":"7","author":"Kanai","year":"1993","journal-title":"FASEB J"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.2006.03978.x","article-title":"The neuronal excitatory amino acid transporter EAAC1\/EAAT3: does it represent a major actor at the brain excitatory synapse?","volume":"98","author":"Nieoullon","year":"2006","journal-title":"J Neurochem"},{"issue":"13","key":"10.1097\/CHI.0b013e318185d2be_bib59","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1093\/emboj\/16.13.3822","article-title":"Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration","volume":"16","author":"Peghini","year":"1997","journal-title":"EMBO J"},{"key":"10.1097\/CHI.0b013e318185d2be_bib60","unstructured":"O'Neill J, Gorbis E, Feusner J, et al. 1H MRSI study of effects of cognitive-behavioral therapy on obsessive-compulsive disorder. Paper presented at ISMRM 15th Scientific Meeting and Exhibition, May 19\u201325, 2007, Berlin."},{"key":"10.1097\/CHI.0b013e318185d2be_bib61","unstructured":"O'Neill J, Gorbis E, Feusner J, et al. 1H MRSI study of effects of cognitive-behavioral therapy on obsessive-compulsive disorder. Paper presented at Organization for Human Brain Mapping, June 12, 2007, Chicago."},{"key":"10.1097\/CHI.0b013e318185d2be_bib62","unstructured":"O'Neill J, Gorbis E, Feusner J, et al. Effects of cognitive-behavioral therapy on regional neurometabolism in obsessive-compulsive disorder. Paper presented at ISNR 15th Annual Conference; September 6\u20139, 2007; San Diego."},{"key":"10.1097\/CHI.0b013e318185d2be_bib63","unstructured":"Zurowski B, Fahr WW, Freyer T, et al. Neurochemical abnormalities in patients with obsessive-compulsive disorder diminish in the course of behavior therapy. Paper presented at Society for Neuroscience 37th Annual Meeting, November 3\u20137, 2007, San Diego."},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","article-title":"Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study","volume":"174","author":"Arnold","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(02)00302-9","article-title":"The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications","volume":"97","author":"Loftis","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.gim.0000250507.96760.4b","article-title":"Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis","volume":"9","author":"Li","year":"2007","journal-title":"Genet Med"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib67","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1601-183X.2006.00273.x","article-title":"Association of the glutamate receptor subunit gene GRIN2B with attention-deficit\/hyperactivity disorder","volume":"6","author":"Dorval","year":"2007","journal-title":"Genes Brain Behav"},{"issue":"2\u20133","key":"10.1097\/CHI.0b013e318185d2be_bib68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2006.02.001","article-title":"N-methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels","volume":"84","author":"Martucci","year":"2006","journal-title":"Schizophr Res"},{"issue":"6467","key":"10.1097\/CHI.0b013e318185d2be_bib69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/368144a0","article-title":"Changing subunit composition of heteromeric NMDA receptors during development of rat cortex","volume":"368","author":"Sheng","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-0186(01)00008-0","article-title":"Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain","volume":"39","author":"Beas-Zarate","year":"2001","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0169-328X(02)00325-X","article-title":"Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice","volume":"104","author":"Ueda","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"10.1097\/CHI.0b013e318185d2be_bib72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJMcp031002","article-title":"Clinical practice. Obsessive-compulsive disorder","volume":"350","author":"Jenike","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pscychresns.2005.12.006","article-title":"A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety","volume":"146","author":"Whiteside","year":"2006","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib74","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutama-tergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib75","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00001756-200403220-00025","article-title":"Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder","volume":"15","author":"Delorme","year":"2004","journal-title":"Neuroreport"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.mp.4001144","article-title":"A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry","volume":"7","author":"Nordstrom","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","article-title":"Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder","volume":"3","author":"Pittenger","year":"2006","journal-title":"NeuroRx"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00213-003-1396-z","article-title":"Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder","volume":"167","author":"Coric","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib79","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.ajp.161.1.171","article-title":"An open-label trial of riluzole in patients with treatment-resistant major depression","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","article-title":"An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression","volume":"57","author":"Zarate","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1097\/CHI.0b013e318185d2be_bib82","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1176\/appi.ajp.161.11.2132","article-title":"Riluzole augmentation for treatment-resistant depression","volume":"161","author":"Sanacora","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2006.08.037","article-title":"Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms","volume":"61","author":"Sanacora","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"issue":"6 suppl 4","key":"10.1097\/CHI.0b013e318185d2be_bib85","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1212\/WNL.47.6_Suppl_4.242S","article-title":"A confirmatory dose-ranging study of riluzole in ALS. ALS\/Riluzole Study Group-II","volume":"47","author":"Lacomblez","year":"1996","journal-title":"Neurology"},{"issue":"9013","key":"10.1097\/CHI.0b013e318185d2be_bib86","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib87","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/exnr.1997.6554","article-title":"Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies","volume":"147","author":"Stefani","year":"1997","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib88","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/sj.bjp.0703424","article-title":"Effects of riluzole on electrically evoked neurotransmitter release","volume":"130","author":"Jehle","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1097\/CHI.0b013e318185d2be_bib89","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1046\/j.1460-9568.2000.00242.x","article-title":"Riluzole inhibits the persistent sodium current in mammalian CNS neurons","volume":"12","author":"Urbani","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib90","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/cap.2007.0021","article-title":"An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder","volume":"17","author":"Grant","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1097\/CHI.0b013e318185d2be_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.mp.4001777","article-title":"Cure therapeutics and strategic prevention: raising the bar for mental health research","volume":"11","author":"Insel","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"17","key":"10.1097\/CHI.0b013e318185d2be_bib92","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.294.17.2221","article-title":"Psychiatry as a clinical neuroscience discipline","volume":"294","author":"Insel","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/09540260701564849","article-title":"Brain imaging research: does the science serve clinical practice?","volume":"19","author":"Wong","year":"2007","journal-title":"Int Rev Psychiatry"},{"issue":"1\u20132","key":"10.1097\/CHI.0b013e318185d2be_bib94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10354-007-0448-0","article-title":"Genetics of autoimmune diabetes mellitus","volume":"158","author":"Cerna","year":"2008","journal-title":"Wien Med Wochenschr"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib95","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.mco.0000172573.25902.33","article-title":"Calpain 10 and type 2 diabetes: are we getting closer to an explanation?","volume":"8","author":"Ridderstrale","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MCO.0b013e3281e3888d","article-title":"HNF4A genetic variants: role in diabetes","volume":"10","author":"Love-Gregory","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1097\/CHI.0b013e318185d2be_bib97","series-title":"Diagnostic and Statistical Manual of Psychiatric Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"9","key":"10.1097\/CHI.0b013e318185d2be_bib98","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopsych.2005.05.007","article-title":"Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study","volume":"58","author":"Rosenberg","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1097\/CHI.0b013e318185d2be_bib99","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mrm.20063","article-title":"Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES","volume":"51","author":"Kanowski","year":"2004","journal-title":"Magn Reson Med"},{"issue":"5","key":"10.1097\/CHI.0b013e318185d2be_bib101","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mrm.1104","article-title":"Single-voxel proton MRS of the human brain at 1.5T and 3.0T","volume":"45","author":"Barker","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1097\/CHI.0b013e318185d2be_bib102","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/bmb\/65.1.259","article-title":"Imaging genomics","volume":"65","author":"Hariri","year":"2003","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1097\/CHI.0b013e318185d2be_bib103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/MN:25:2:191","article-title":"Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?","volume":"25","author":"Schiffer","year":"2002","journal-title":"Mol Neurobiol"},{"issue":"4284","key":"10.1097\/CHI.0b013e318185d2be_bib104","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1126\/science.14400","article-title":"Glutamine synthetase: glial localization in brain","volume":"195","author":"Martinez-Hernandez","year":"1977","journal-title":"Science"},{"issue":"7","key":"10.1097\/CHI.0b013e318185d2be_bib105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81674-8","article-title":"Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission","volume":"99","author":"Chaudhry","year":"1999","journal-title":"Cell"},{"issue":"6","key":"10.1097\/CHI.0b013e318185d2be_bib106","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1074\/jbc.275.6.4049","article-title":"Cloning and functional identification of a neuronal glutamine transporter","volume":"275","author":"Varoqui","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1097\/CHI.0b013e318185d2be_bib107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0076-6879(85)13033-8","article-title":"Glutaminase from mammalian tissues","volume":"113","author":"Kvamme","year":"1985","journal-title":"Methods Enzymol"},{"key":"10.1097\/CHI.0b013e318185d2be_bib108","first-page":"261","article-title":"Proton MRS: GABA and glutamate","volume":"83","author":"Petroff","year":"2000","journal-title":"Adv Neurol"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856708601185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856708601185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T14:03:22Z","timestamp":1684591402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856708601185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0890856708601185"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e318185d2be","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}